Track topics on Twitter Track topics that are important to you
NEW ORLEANS — The initial clinical results of hypersonic vitrectomy in 46 cases in the United States since Sept. 27, 2017, have been encouraging, according to a speaker here.
“The hypersonic vitrectomy device has been FDA approved. Our initial clinical experience is encouraging, but there is much more to learn and more to come,” Carl C. Awh, MD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting.
Hypersonic vitrectomy is a new method of vitreous removal in which ultrasonic power is used to actuate the vitrectomy probe in the Vitesse device
Original Article: Hypersonic vitrectomy has early encouraging clinical successNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...